BioSpace News Archive

Biotech Beach

aTyr Pharma to Present at Upcoming Investor Conferences in March

aTyr Pharma, Inc. today announced that Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer, will present at two upcoming investor conferences in March.

March 3, 2022
·
1 min read
Biotech Beach

Dr. Anthony E. Maida will be presenting at the Marcus Evans Evolution Summit

Oncotelic Therapeutics, Inc. and Marcus Evans are proud to announce Dr Anthony E. Maida, Chief Clinical Officer – Translational Medicine for Oncotelic, Inc. as a speaker at the upcoming annual Evolution Summit taking place in Los Angeles this month.

March 3, 2022
·
7 min read
Pharm Country

VBL Therapeutics to Participate at March 2022 Investor Conferences

VBL Therapeutics announced that management will participate in a fireside chat at the 34th Annual Roth Conference being held on March 13 - 15, 2022 as well as at the 32nd Annual Oppenheimer Healthcare Conference taking place on March 15 - 17, 2022.

March 3, 2022
·
1 min read
Business

electroCore to Announce Fourth Quarter and Year Ended December 31, 2021 Financial Results on Thursday, March 10

electroCore, Inc. announced today that it will report financial results for the fourth quarter and year ended December 31, 2021, after the close of the market on Thursday, March 10, 2022.

March 3, 2022
·
1 min read
Biotech Beach

Codex DNA Announces Registration and Webcast Information for Upcoming R&D Webinar on March 29, 2022

Codex DNA, Inc. today announced details for its first Investor R&D Webinar. Management will describe the future promise of the company’s R&D pipeline, with a specific focus on its proprietary Short Oligo Ligation Assembly (SOLA) enzymatic DNA synthesis technology.

March 3, 2022
·
1 min read
Business

Selecta Biosciences to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2021 Financial Results and Provide Business Update

Selecta Biosciences, Inc. today announced that it plans to host a conference call on Thursday, March 10, 2021, at 8:30 a.m. ET to discuss its financial results for the quarter and full-year ended December 31, 2021 and provide a business update.

March 3, 2022
·
1 min read
Pharm Country

TG Therapeutics Announces Extension of U.S. FDA BLA/sNDA PDUFA Date for Ublituximab Plus UKONIQ® (U2) to Treat Patients with CLL and SLLFDA sets updated PDUFA goal date of June 25, 2022

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date to June 25, 2022 for the Biologics License Application (BLA) and supplemental New Drug Application (sNDA) for ublituximab.

March 3, 2022
·
15 min read
Pharvaris to Participate in Upcoming March 2022 Investor Conferences

Pharvaris announced that management will participate in three upcoming investor conferences in March.

March 3, 2022
·
1 min read
Biotech Bay

NephroSant Publishes Real-World Evidence Showing Potential to Improve the Detection of Early Rejection Events with QSant

NephroSant™ announced that the Journal of Clinical Medicine has published real-world data (RWD) that provides insight into how changes in allograft health are reflected in specific ranges of QSant™ scores.

March 3, 2022
·
4 min read
Fluid Warmer Devices Market: Growing need for Intravenous Treatments to Drive the Market

Albany NY, United States: The global market for fluid warmer devices has been rising on account of advancements in the field of surgical procedures.

March 3, 2022
·
5 min read